English
Spanish
French
Italian
German
NEWS ARCHIVE
Explore our archive of news and updates from the HS Foundation — a curated collection of stories, milestones, and announcements from over the years.
Raising the Bar for HS Outcomes With Barry Resnik, MD
March 15, 2026
Years-long diagnostic delays and incremental treatment approaches have left many patients struggling. Barry Resnik shares how earlier escalation, clearer treatment goals, and a focus on function, not just lesions, could change the trajectory of hidradenitis suppurativa care.
Read more
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
March 5, 2026
A team of dermatology experts has just agreed on a standardized way to identify and classify HS lesions, potentially transforming how clinical trials measure disease and evaluate treatments. Find out how this new consensus could reshape research and bring us closer to better therapies.
Read more
Understanding Moderate Hidradenitis Suppurativa: Diagnosis, Impact, and Treatment
February 25, 2026
Explore why early recognition and tailored care are vital for patients with moderate hidradenitis suppurativa. This Dermatology Times piece breaks down key challenges in diagnosis, the real impact on quality of life, and evolving treatment strategies, including when to consider systemic and biologic therapies to prevent disease progression.
Read more
“I Lost 15 Years of My Life”: A Man’s Journey With Hidradenitis Suppurativa
February 25, 2026
In a revealing interview conducted by The Educated Patient, Keven Brown opens up about his long, painful battle with hidradenitis suppurativa — from years of misdiagnosis and physical hardship to the emotional toll of living with a chronic condition and the resilience it took to reclaim his life.
Read more
Do GLP-1 medications help signs and symptoms of Hidradenitis Suppurativa?
February 23, 2026
Could a medication commonly used for type 2 diabetes and weight loss also help improve hidradenitis suppurativa? New research explores the potential impact of GLP-1 receptor agonists on HS signs, symptoms, and quality of life. Click to learn what researchers found and what it could mean for people living with HS.
Read more
Hidradenitis Suppurativa in Patients with Skin of Color: Emerging Therapies and Strategies for Effective Management
January 22, 2026
New insights highlight emerging therapies and practical strategies for managing hidradenitis suppurativa in patients with skin of color. Learn how evolving treatments, improved diagnostic approaches, and patient-centered care are reshaping HS management and addressing long-standing gaps in care.
Read more
Timing, Severity, and Therapeutic Choice in Moderate to Severe HS
January 14, 2026
When should HS treatment escalate? This case-based discussion with HS Foundation board member, Dr. Afsaneh Alavi, explores how timing, severity assessment, and therapeutic choice shape outcomes in moderate to severe hidradenitis suppurativa.
Read more
Beyond the Surface: January 2026
January 13, 2026
Catch the latest from the Hidradenitis Suppurativa Foundation — explore new HS insights, updated wound care resources, SHSA 2026 details, and apply for the Mentored Experience Grant by January 31.
Read more
New HS Health Resources Available on Educated Patient
January 5, 2026
A new Hidradenitis Suppurativa Health Resources Hub is now available on the Educated Patient website, offering clear, evidence-based information on HS risk factors, signs and symptoms, diagnosis, treatment options, and more.
Read more
Turning Action Plans Into Power: Personalizing Care for Patients With Hidradenitis Suppurativa
December 16, 2025
Learn how personalized action plans can empower patients with hidradenitis suppurativa by improving communication, clarifying flare management, and supporting more proactive, individualized care.
Read more
Hot Off the Press: SHSA 2025 Abstracts Published in Dermatology & Therapy
December 1, 2025
The full collection of abstracts presented at the 10th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) has officially been published in the open access journal Dermatology & Therapy. This milestone release makes the latest HS research from international clinicians and scientists widely available to the community.
Read more
Why HS Is So Often Misdiagnosed, With Steven Daveluy, M.D.
November 25, 2025
Many people with Hidradenitis Suppurativa (HS) suffer in silence — not because the disease is rare, but because it’s too often misunderstood. In a revealing interview, Dr. Steven Daveluy uncovers the myths, missed signals and clinical blind spots that delay diagnosis and care.
Read more
Danby Research Grant Supports New Insights into HS
November 18, 2025
Support from the HS Foundation’s Danby Research Grant enabled Dr. Fang’s work examining the cellular mechanisms involved in HS. Her findings are helping to clarify how immune structures form in the skin and may inform future targeted treatment approaches.
Read more
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
November 16, 2025
Pain, stigma, and delays still too often define the journey for patients with Hidradenitis Suppurativa (HS). This feature HSF leader, Dr. Gretchen Roth, in the Dermatologist offers dermatologists a roadmap to turn HS visits into moments of trust-building, actionable care, and real hope. From empathetic communication to tailored management strategies, learn how one clinic’s compassion driven approach can reshape outcomes for this complex condition.
Read more
Surgical Collaboration Strengthens HS Outcomes Across Disease Stages
November 4, 2025
Surgery is not just a last resort for Hidradenitis Suppurativa (HS) anymore. New collaborative models between dermatologists, surgeons and researchers are transforming outcomes across all disease stages, from localized cases to advanced disease. Discover how this multidisciplinary shift is redefining HS treatment.
Read more
Alexa Kimball, MD, on the Future of HS Care
October 22, 2025
Dr. Alexa Kimball shares insights on the future of hidradenitis suppurativa care — from earlier diagnosis and better treatment strategies to integrating comorbidities into research. She also explores emerging therapies like GLP-1 receptor agonists and what’s next for advancing HS management.
Read more
Recognizing HS: From First Signs to an Accurate Diagnosis
October 16, 2025
Hidradenitis suppurativa is often misunderstood and underdiagnosed—even though its telltale signs can emerge early. Explore how key symptoms like painful nodules, abscesses, and draining tunnels can offer a pathway to timely diagnosis and more compassionate, effective care.
Read more
Beyond the Surface: October 2025
October 10, 2025
This month’s newsletter features exciting updates on the new HS Buddy Program, details for SHSA 2025 in Nashville, current grant opportunities, and the latest HS in the News. Don’t miss what’s happening in the HS community — check it out now!
Read more
Can Quitting Smoking Lower the Risk of Hidradenitis Suppurativa?
September 29, 2025
A new study of more than 6 million people shows that quitting smoking can cut the risk of hidradenitis suppurativa by about one-third—but the benefits appear only after staying smoke-free for at least three years. Relapsing, however, brings the risk right back up.
Read more
HS Summit Spotlights Gaps in Diagnosis and Care
September 11, 2025
The summit highlighted the challenges of diagnosing HS, emphasizing the need for awareness & recognizing chronic, recurrent patterns. Patient storytelling & joint panels underscored the real-world burden of HS & the importance of early intervention. Collaboration between patients & providers is crucial for improving outcomes & raising the standard of care in HS management.
Read more